How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

229 results for

Microdermabrasion

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Nonablative Facial Skin Tightening

for the person who is unable to afford the downtime of more aggressive procedures and is dissatisfied with the minimal gains achieved from superficial peels and microdermabrasion. Previous References Vanaman M, Fabi SG, Carruthers J. Complications in the Cosmetic Dermatology Patient: A Review and Our Experience (Part 1). Dermatol Surg . 2016 Jan. 42 (1):1-11. . Vanaman M, Fabi SG, Carruthers J. Complications in the Cosmetic Dermatology Patient: A Review and Our Experience (Part 2). Dermatol Surg . 2016 Jan

2014 eMedicine Surgery

122. Skin Resurfacing: Chemical Peels

in the supplantation of this technique by those already discussed. Microdermabrasion is currently a popular technique because no downtime or discomfort is associated with the procedure. Medical devices tend to have stronger suction, and more abrasive crystals are used, while spa and lay devices tend to be gentler, with less overall effect but increased safety. In general, mechanical abrasion tends to improve scarring more than chemical peeling agents, given similar depth of penetration. [ ] Currently, a number

2014 eMedicine Surgery

123. Skin Resurfacing, Chemical Peels

in the supplantation of this technique by those already discussed. Microdermabrasion is currently a popular technique because no downtime or discomfort is associated with the procedure. Medical devices tend to have stronger suction, and more abrasive crystals are used, while spa and lay devices tend to be gentler, with less overall effect but increased safety. In general, mechanical abrasion tends to improve scarring more than chemical peeling agents, given similar depth of penetration. [ ] Currently, a number

2014 eMedicine Surgery

124. Scar Revision

. Previous Next: Contraindications Cigarette smoking, nonsteroidal anti-inflammatory drugs, vitamin E, and isotretinoin should be stopped at the appropriate time prior to revision, or the patient should be counseled that suboptimal outcomes may result. Noninvasive or minimally invasive measures such as microdermabrasion and intralesional steroid injection can be performed as early as 3 weeks after revision of the scar, but many practitioners prefer to wait 6 weeks. When undertaking a revision, subtle

2014 eMedicine Surgery

125. Postinflammatory Hyperpigmentation (Diagnosis)

the skin such as infections, allergic reactions, mechanical injuries, reactions to medications, phototoxic eruptions, trauma (eg, burns), and inflammatory diseases (eg, , , ). Postinflammatory hyperpigmentation can also be seen following treatment with a number of electromagnetic devices such as ultrasound, radiofrequency, lasers, light-emitting diodes, and visible light, as well as secondary to microdermabrasion. Typically, postinflammatory hyperpigmentation is most severe in patients whose basal cell

2014 eMedicine.com

126. Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.

of a metal stent or implant in the area(s) to be treated. Inability to understand the protocol or to give informed consent. Microdermabrasion, or prescription level glycolic acid treatment to the treatment area(s) within three months prior to study participation or during the study. Intralesional kenalog in the past 6 months. History of chronic drug or alcohol abuse. History of autoimmune disease. Concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety

2013 Clinical Trials

127. Poly-L-lactic Acid for Skin Quality

nasolabial fold contour deficiencies or other facial wrinkles Subjects who agree not to have any procedures affecting facial wrinkles (e.g. filler, botulinum toxin, radiofrequency, laser, IPL, ultrasound) for the duration of the study Subjects who do agree not to have any other procedures affecting skin quality (microdermabrasion, peels, acne treatments, etc.) for the duration of the study Subjects who understand this study and are able to follow study instructions and are willing to attend the required

2013 Clinical Trials

128. A Study of Nutritional Supplementation in Altering Ecchymosis, Erythema and Health Outcomes Associated With Aesthetic Procedures

of nutritional supplementation (14 day washout period) Retinoid, microdermabrasion, or prescription level glycolic acid treatments to the malar area within 2 weeks prior to study participation or during the study. Active infection in the malar area (e.g., acute acne lesions or ulcers). Current history of chronic drug or alcohol abuse. History of autoimmune disease. Current history of blood thinners (aspirin, ibuprofen, naprosyn, herbal supplements, Vitamin E, etc.) Current history of tobacco use Concurrent

2013 Clinical Trials

129. An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

. Subject has any skin or medical condition, including facial hair that could interfere with the evaluation of the test article or requires the use of interfering topical or systemic therapy. Subject has the need or plans to be exposed to artificial tanning devices or excessive sunlight during the study. Subject has used light treatments, microdermabrasion or chemical peels to the face, chest and back within eight weeks of study start. Subject cannot avoid any type of strenuous exercise (swimming

2013 Clinical Trials

130. Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines

to 60 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: moderate or severe frown lines facial laser treatment between 4 to 8 weeks prior to Day 1 Exclusion Criteria: previous use of botulinum toxin for any indication diagnosis of myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis microdermabrasion or superficial peels, permanent make-up to the brow and forehead area within the last 3 months facial cosmetic procedures within

2013 Clinical Trials

131. Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment

Planus, Vitiligo or Psoriasis in the treatment area that in the investigators opinion, would put the subject at unnecessary risk. Inability to understand the protocol or to give informed consent. Microdermabrasion, or prescription level glycolic acid treatments to the intended treatment area(s) within two weeks prior to study participation or during the study. History of chronic drug or alcohol abuse. History of autoimmune disease. Concurrent therapy that, in the investigator's opinion, would

2013 Clinical Trials

132. Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face

anesthetics of the amide or ester family Known allergies to gentamicin and/or streptomycin Receiving any topical products containing alpha-hydroxy acids, salicylic acid, and Vitamins C or E (including derivatives of Vitamins C or E) on the face within 14 days prior to or during the study period, other than the ingredients of the study products Receiving and/or has had a microdermabrasion (light or medium skin peel) treatment on their face within 30 days prior to or during the study period Using any

2013 Clinical Trials

133. To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

of certain vitamins (such as vitamin D and vitamin B12), haloperidol, halogens such as iodide and bromide, lithium, hydantoin and phenobarbital. Facial procedures (chemical or laser peel, microdermabrasion, etc.) within the past 2 weeks or during the study. Concomitant use of tanning booths or sunbathing. A significant medical history of or are currently immunocompromised Have any systemic or dermatologic disease that may affect the evaluation of study results. Have a history of regional enteritis

2013 Clinical Trials

134. Peri-orbital and Peri-oral Wrinkle Reduction Trial

. Microdermabrasion, or prescription level glycolic acid treatment to the treatment area(s) within 4 weeks prior to study participation or during the study. Marked asymmetry, ptosis, excessive dermatochalasis, deep dermal scarring, or thick sebaceous skin in the area(s) to be treated. History of chronic drug or alcohol abuse. History of autoimmune disease. History of Bell's Palsy or epilepsy. History of diabetes. Has a known allergy, or a known history of sensitivity, to lidocaine, tetracaine, para-aminobenzoic

2013 Clinical Trials

135. A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel

the study. Hormonal therapies include, but are not limited to, estrogenic and progestational agents such as birth control pills. Use of androgen receptor blockers (such as spironolactone or flutamide) Oral retinoid use (e.g., isotretinoin) within 12 months prior to baseline or vitamin A supplements greater than 10,000 units/day within 6 months of baseline. Facial procedures (chemical or laser peel, microdermabrasion, etc.) within the past 8 weeks or during the study. Contacts and Locations Go

2013 Clinical Trials

136. Efficacy and Safety of Injection With VINCI Plus Hyaluronic Acid Filler

during clinical trial Within 6 months before date of screening, subject has received anti-wrinkle or acne treatment Within 6 months before date of screening, subject has received facial microdermabrasion treatment, skin regeneration/rejuvenation treatment, plastic surgery, or cosmetic surgery (including Botox injections) Within 1 year before date of screening, subject has received CaHA (Calcium Hydroxyapatite) treatment on clinical trial medical device treatment area Subject has cured facial gel

2013 Clinical Trials

137. BOTOX® in the Treatment of Upper Facial Lines in Japan

. For general information, Layout table for eligibility information Ages Eligible for Study: 20 Years to 64 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: -Moderate to severe Crow's Feet Lines and Frown Lines Exclusion Criteria: Current or previous botulinum toxin treatment of any serotype Diagnosis of Myasthenia gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis Facial laser or light treatment for cosmetic purposes, microdermabrasion

2013 Clinical Trials

138. BOTOX® in the Treatment of Crow's Feet Lines in Japan

for Study: 20 Years to 64 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: -Moderate to severe Crow's Feet Lines Exclusion Criteria: Current or previous botulinum toxin treatment of any serotype Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis Facial laser or light treatment for cosmetic purposes, microdermabrasion, superficial peels, or topical retinoid therapy or hormone cream within 3 months Laser treatment

2013 Clinical Trials

139. Chemical Peel

, Chemexfoliation II. Mechanism Chemical exfoliation of superficial skin layers using acids or enzymes (e.g. hydroxy acids) III. Indications (same indications as for Microdermabrasion) Benign epidermal pigmentation Rough skin Superficial acne scars IV. Dosing Course of 6 treatments every 4 weeks with maintenance treatments every 1-3 months V. Preparations Alpha hydroxy acids Lactid acid Beta hydroxy acids Salicylic acid VI. Efficacy Results are temporary VII. Advantages Inexpensive VIII. Disadvantages Difficult

2015 FP Notebook

140. Effect of Subcision and Suction on Acne Scars

Assignment Masking: Single (Outcomes Assessor) Primary Purpose: Treatment Official Title: Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Subcision and Suctioning With a Microdermabrasion Device on Rolling Acne Scars Study Start Date : September 2012 Estimated Primary Completion Date : September 2019 Estimated Study Completion Date : September 2019 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment

2012 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>